Skip to main content
. 2017 Apr 10;37(2):BSR20160557. doi: 10.1042/BSR20160557

Table 1.

Characteristics of these included studies

Author (year) Country Duration of intervention Follow-up duration Subjects Group Sample size M/F Age Criteria for evaluating depression Baseline values
der Ven, N.C.V.
(2005)
Netherlands 3 months 0 months Type 1 diabetes CBT 45 36/52 37.8 ± 10.6 CES-D 16.0 ± 11.0
Control: blood glucose awareness training 43
Piette, J.D.
(2011)
U.S.A. 12 months 0 months Type 2 diabetes CBT 145 72/73 55.1 ± 9.4 BDI 26.7 ± 7.7
Control: usual care 146 73/73 56.0 ± 10.9 26.5 ± 9.9
Safren, S.A.
(2014)
U.S.A. 4 months 12 months Type 2 diabetes CBT 45 22/23 55.44 ± 8.72 MADRS 25.60 ± 8.99
CGI 4.42 ± 1.29
Control: enhanced treatment as usual 42 22/20 58.31 ± 7.41 MADRS 23.31 ± 7.20
CGI 3.98 ± 1.09
Laura, M.C.
(2013)
Netherlands NA 12 months Type 2 diabetes CBT 76 45/31 60.5 ± 9.4 CES-D 11.1 ± 8.1
Control: managed care 78 50/28 61.2 ± 8.8 9.6 ± 8.2
Hermanns, N.
(2015)
Germany NA 12 months Diabetes mellitus CBT 106 56/60 43.2 ± 14.9 CES-D 24.7 ± 7.6
PHQ-9 10.9 ± 4.3
Control: diabetes education 108 57/61 43.4 ± 13.8 CES-D 22.4 ± 8.6
PHQ-9 9.6 ± 3.8